Skip to content

Pulse radiofrequency treatment of postherpetic neuralgia with different voltages and different durations

Pulse radiofrequency treatment of postherpetic neuralgia with different voltages and different durations

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097783
Enrollment
Unknown
Registered
2025-02-25
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic neuralgia

Interventions

High voltage short duration group (HS)
:High voltage short range pulse RF
High voltage long duration group (HL)
:High voltage long duration pulse RF
Conventional voltage short-time range group(SS)
:11/5000 Conventional voltage short-range pulse RF
Conventional voltage long duration group (SL):Conventional voltage long duration pulse RF

Sponsors

Chengdu Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Age 18-75 years old; 2.ASAI~ Level II; 3.No gender limitation; 4.Pain VAS score >=4; 5.Pain duration >=1 month; 6.The results of MRI or CT imaging suggest no secondary causes such as tumors or hemorrhage;

Exclusion criteria

Exclusion criteria: 1.Local anesthetics and other perioperative drug allergies; 2.Pregnant or serious cardiovascular and cerebrovascular diseases; 3.Infection (signs + laboratory tests) suspicious; 4.Patients with infection at the puncture site; 5.Myelitis, tepid cord, spinal cord tumor, vertebral fracture; 6.Patients with severe mental illness who are unable to cooperate; 7.Patients with blood clotting dysfunction; 8.Prior to PRF, other interventional procedures were performed; PRF also received other interventional procedures; 9.Accompanied by other neuropathic pain.

Design outcomes

Primary

MeasureTime frame
Pain assessment;

Secondary

MeasureTime frame
Patient satisfaction score;Therapeutic effectiveness;Postoperative complication;Sleep quality assessment;

Countries

China

Contacts

Public ContactLijie Wang

Chengdu Second People's Hospital

769900497@qq.com+86 28 6783 0879

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026